Ironwood Pharmaceuticals | IRWD - Operating Profit


Ironwood Pharmaceuticals reported $33.22M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Acadia Pharmaceuticals USD 17.39M 18.36M Dec/2025
Agios Pharmaceuticals USD -121.58M 4.71M Dec/2025
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Almirall EUR 30.23M 12.8M Dec/2025
Alnylam Pharmaceuticals USD 29.4M 59.36M Dec/2025
Amarin USD -2.26M 564K Dec/2025
Ardelyx USD 5.1M 431K Dec/2025
Astellas Pharma JPY 48.57B 85.97B Mar/2026
AstraZeneca USD 2.97B 4.48B Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Emergent BioSolutions USD -218M 69.9M Jun/2023
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Incyte USD 383.88M 47.43M Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Karyopharm Therapeutics USD -17.84M 13.44M Dec/2025
Lexicon Pharmaceuticals USD -14.78M 2.59M Dec/2025
MacroGenics USD -12.1M 30.74M Dec/2025
Moderna USD -857M 597M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
Pacira USD 3.19M 9.96M Dec/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Puma Biotechnology USD 22.08M 24.26M Sep/2024
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
Takeda JPY 168.82B 479.89B Dec/2025
Ultragenyx Pharmaceutical USD -114M 56.89M Dec/2025
Vanda Pharmaceuticals USD -40.66M 29.66M Dec/2024